Entera Bio (ENTX) Other Operating Expenses (2021 - 2023)

Entera Bio (ENTX) has reported Other Operating Expenses for 3 consecutive years, with $10000.0 the latest figure, recorded in Q4 2023.

• Quarterly Other Operating Expenses fell 44.44% year-over-year to $10000.0 in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $10000.0 (down 82.46% YoY) and the FY2023 annual result came in at $49000.0, down 3.92% from the prior year.
• Other Operating Expenses eased to $10000.0 in Q4 2023 per ENTX's latest filing, from $12000.0 in the prior quarter.
• Over the last five years, Other Operating Expenses for ENTX reached as high as $18000.0 in Q4 2022 and fell as low as $6000.0 in Q3 2022.
• A 3-year average of $12083.3 and a median of $12000.0 in 2022 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2022 — Other Operating Expenses tumbled 45.45% — and 2023, when it soared 100.0%.
• Year by year, Other Operating Expenses stood at $14000.0 in 2021, then grew by 28.57% to $18000.0 in 2022, then slumped by 44.44% to $10000.0 in 2023.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $10000.0, $12000.0, and $14000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.